logo-loader
NASDAQ:ADXN SIX:ADXN

Addex Therapeutics Ltd

Receive alerts
Market:
NASDAQ
Price
3.40 USD
Day Change
11.11%
Market Cap:
$5.96 m
52 weeks high
10.43
52 weeks low
-

In brief

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.

The company's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is under evaluation for future development in brain injury recovery, including post-stroke and traumatic brain injury recovery.